Clinical trials
Terminated Phase 4 Pulmonary Disease, Chronic Obstructive trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 2 |
| 2008 | 1 |
| 2010 | 1 |
| 2012 | 4 |
| 2013 | 2 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Boehringer Ingelheim | 2 |
| IRCCS Azienda Ospedaliero-Universitaria di Bologna | 2 |
| Aeris Therapeutics | 1 |
| Brigham and Women's Hospital | 1 |
| Capital Medical University | 1 |
| Chronic Obstructive Pulmonary Disease Trial Network, Denmark | 1 |
| Columbia University | 1 |
| Esbjerg Hospital - University Hospital of Southern Denmark | 1 |
| Fundacio Privada Mon Clinic Barcelona | 1 |
| GlaxoSmithKline | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Disease, Chronic Obstructive | 24 |
| Bronchitis, Chronic | 3 |
| Asthma | 2 |
| Emphysema | 2 |
| Bronchiectasis | 1 |
| Inflammation | 1 |
| Lung Diseases, Obstructive | 1 |
| Pseudomonas Infections | 1 |
| Pulmonary Emphysema | 1 |
| Respiratory Tract Infections | 1 |
Trials
Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.